| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.27 | 0.05 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |